Raymond James & Associates’s Innovator US Equity Buffer ETF April BAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.11M Sell
25,613
-125
-0.5% -$5.25K ﹤0.01% 2630
2024
Q2
$1.07M Buy
25,738
+28
+0.1% +$1.12K ﹤0.01% 2583
2024
Q1
$1.03M Sell
25,710
-500
-2% -$19.6K ﹤0.01% 2577
2023
Q4
$1M Sell
26,210
-3,360
-11% -$122K ﹤0.01% 2520
2023
Q3
$1.03M Sell
29,570
-230
-0.8% -$8.25K ﹤0.01% 2441
2023
Q2
$1.07M Buy
29,800
+5,265
+21% +$180K ﹤0.01% 2431
2023
Q1
$823K Hold
24,535
﹤0.01% 2579
2022
Q4
$761K Hold
24,535
﹤0.01% 2596
2022
Q3
$713K Buy
24,535
+3,000
+14% +$93.4K ﹤0.01% 2600
2022
Q2
$644K Sell
21,535
-6,411
-23% -$203K ﹤0.01% 2743
2022
Q1
$948K Buy
+27,946
New +$916K ﹤0.01% 2636

Other funds holding BAPR

Raymond James & Associates's BAPR Position: Q3 2024 in Review

Raymond James & Associates reduced its Innovator US Equity Buffer ETF April (BAPR) stake by 0.49% in Q3 2024, selling an estimated $5.25K and leaving 25,613 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

Raymond James & Associates first reported a position in BAPR in Q1 2022 and has held it in 11 quarters since. 100 funds tracked by Wall St. Rank hold BAPR as of Q3 2024.

  • Raymond James & Associates held 25,613 shares of Innovator US Equity Buffer ETF April worth $1.11M as of Q3 2024.
  • Raymond James & Associates sold 125 Innovator US Equity Buffer ETF April shares in Q3 2024, an estimated $5.25K.
  • Innovator US Equity Buffer ETF April made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2630 holding.
  • Raymond James & Associates first reported a position in Innovator US Equity Buffer ETF April in Q1 2022 and has held it in 11 quarters since.
  • 100 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF April as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.